Loading...
Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
BACKGROUND: Transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (HCC) is often repeated until unTACEable progression (UTP) occurs. There is little data on the various reasons for stopping TACE and its consequences for subsequent treatment and survival. AIM: To asse...
Saved in:
| Published in: | Cardiovasc Intervent Radiol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer US
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344387/ https://ncbi.nlm.nih.gov/pubmed/30488302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00270-018-2118-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|